TNXP Institutional Ownership

TONIX PHARMACEUTICALS HOLDIN

Latest close $11.29 as of Aug 5, 2026

Create account to watch
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices. Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes. Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public. Compare plans.
Cross-institution intelligence

Institutional Research

Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.

Latest filing Mar 27, 2026
Public consensus preview Accumulation leaning 65/100 institutional research score
2 tracked institutions Latest filing Mar 27, 2026

1 accumulating across 1 comparable institution.

Accumulating1
Unchanged0
Reducing0
Exited0

The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.

Price context

52-week position is market context and does not change the institutional consensus score.

52-week low$13.07 52-week high$69.97
Latest close $11.29 0.0% through the range

Tracked institutions

Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.

Latest observation Mar 13, 2026
BlackRock Jan 21, 2026 filed
Vanguard Group Mar 27, 2026 filed
Detailed institutional research

See what is driving the consensus.

Unlock holder-by-holder changes, ownership history, breadth by period, disclosure timing, and filing-specific signal analysis.

Create free account Compare Investor and Pro

A free account adds watchlists and reveals tracker research gauges. Investor or Pro unlocks the detailed research above.

Beneficial ownership filing history

Showing 3 of 3 parsed filing(s)
Holder Observed / filed Reported change Shares Ownership Observation Filing Latest
Vanguard Group CIK0000102909 Mar 13, 2026 observed Mar 27, 2026 filed · 14d Schedule 13G amendment Earliest Schedule 13G amendment found 11 12.00% $13.24 $12.88 $11.29
BlackRock CIK0002012383 Dec 31, 2025 observed Jan 21, 2026 filed · 21d Schedule 13G amendment Reported accumulation 854.6K +174.5K 12.00% 0.00 pts $15.62 $18.17 $11.29
BlackRock CIK0002012383 Sep 30, 2025 observed Oct 17, 2025 filed · 17d Schedule 13G amendment Earliest Schedule 13G amendment found 680.0K 12.00% $24.16 $18.62 $11.29
Explore more institutional activity

Related research

Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.

Similar research strength

GLIBA LIBERTY CAPITAL CORP 65/100 Accumulation leaning EFC ELLINGTON FINANCIAL INC 65/100 Accumulation leaning EFSI EAGLE FINANCIAL SERVICES INC 65/100 Accumulation leaning TALK TALKSPACE INC 65/100 Accumulation leaning

Recent multi-institution accumulation

TVTX Travere Therapeutics, Inc. 2 accumulating Aug 6, 2026 PCVX VAXCYTE INC 2 accumulating Aug 6, 2026 VVX V2X INC 2 accumulating Aug 6, 2026 VSEC VSE CORP 3 accumulating Jul 31, 2026